Validation of the Schiller BR-102 Plus PWA Device to Measure Central and Peripheral Hemodynamics (BR-102)
Primary Purpose
Aortic Stiffness, Hypertension
Status
Terminated
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Pulse wave analysis measurement with Schiller BR-102 Plus PWA device
Sponsored by

About this trial
This is an interventional diagnostic trial for Aortic Stiffness focused on measuring validation, pulse wave analysis, blood pressure monitoring
Eligibility Criteria
Inclusion Criteria:
- Healthy individuals free of clinically relevant cardiovascular diseases or diabetes based on medical history and physical examination.
- Heart rhythm: Sinus rhythm
- Blood pressure range: 10 to 12 subjects in each of the three systolic blood pressure (SBP) and three diastolic blood pressure (DBP) recruitment ranges (low, medium, high).
Exclusion Criteria:
- Cardiac arrhythmia (atrial fibrillation, frequent extrasystoles)
- Pacemaker-dependent
- Pregnancy after the 6th month of the pregnancy
- Body mass index (BMI)>30 kg/m2
- Known significant carotid or femoral artery stenosis
- Impalpable arterial pulse at site of measurement
- Age under 18 years.
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Pulse wave analysis measurement
Arm Description
Measurement of central and peripheral blood pressure and central arterial stiffness simultaneously with the Schiller BR-102 Plus PWA device
Outcomes
Primary Outcome Measures
central blood pressure
Measurement of central blood pressure and central arterial stiffness simultaneously with the Schiller BR-102 Plus PWA device
central arterial stiffness
Measurement of central blood pressure and central arterial stiffness simultaneously with the Schiller BR-102 Plus PWA device
Secondary Outcome Measures
peripheral blood pressure
Measurement peripheral blood pressure with the Schiller BR-102 Plus PWA device
Full Information
NCT ID
NCT02596165
First Posted
October 28, 2015
Last Updated
November 13, 2020
Sponsor
University of Basel
Collaborators
Kantonsspital Liestal
1. Study Identification
Unique Protocol Identification Number
NCT02596165
Brief Title
Validation of the Schiller BR-102 Plus PWA Device to Measure Central and Peripheral Hemodynamics
Acronym
BR-102
Official Title
Validation of the Schiller BR-102 Plus PWA Device to Measure Central and Peripheral Hemodynamics
Study Type
Interventional
2. Study Status
Record Verification Date
November 2020
Overall Recruitment Status
Terminated
Why Stopped
Stopp because of FDA concrns regarding recruitment.
Study Start Date
March 2016 (Actual)
Primary Completion Date
September 2016 (Actual)
Study Completion Date
October 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Basel
Collaborators
Kantonsspital Liestal
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The significance of parameters of the central hemodynamic is based upon their strong association with left ventricular hypertrophy and target organ damage at the heart. Noninvasive, auscultatory/ oscillometric and therefore easy applicable measurements of the central hemodynamic such as presented by the Schiller BR-102 plus PWA device implicate highly promising potential for research and daily clinical praxis for improved cardiovascular risk assessment on the population level. The purpose of this study is to evaluate the validity of the central and peripheral blood pressure and central arterial stiffness measured with the device BR-102 plus PWA from Schiller (Schiller AG, Baar, Switzerland).
Detailed Description
The proposed study is an open, monocentric cross-sectional research study for the evaluation of the validity of the central and peripheral blood pressure and central arterial stiffness measured with the device BR-102 plus PWA from Schiller (Schiller AG, Baar, Switzerland). For that purpose measurement of the respective parameters in cardiovascular disease free individuals will be compared with validated devices and the agreement between the devices will be statistically analyzed. Central blood pressure and central arterial stiffness are clinically increasingly meaningful parameters of the cardiovascular system that allow improved, early cardiovascular risk stratification. The significance of parameters of the central hemodynamic is based upon their strong association with left ventricular hypertrophy and target organ damage at the heart. Noninvasive, auscultatory/ oscillometric and therefore easy applicable measurements of the central hemodynamic such as presented by the Schiller BR-102 plus PWA device implicate highly promising potential for research and daily clinical praxis for improved cardiovascular risk assessment on the population level.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Aortic Stiffness, Hypertension
Keywords
validation, pulse wave analysis, blood pressure monitoring
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
45 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Pulse wave analysis measurement
Arm Type
Experimental
Arm Description
Measurement of central and peripheral blood pressure and central arterial stiffness simultaneously with the Schiller BR-102 Plus PWA device
Intervention Type
Device
Intervention Name(s)
Pulse wave analysis measurement with Schiller BR-102 Plus PWA device
Intervention Description
Measurement of central and peripheral blood pressure and central arterial stiffness simultaneously with the Schiller BR-102 Plus PWA device
Primary Outcome Measure Information:
Title
central blood pressure
Description
Measurement of central blood pressure and central arterial stiffness simultaneously with the Schiller BR-102 Plus PWA device
Time Frame
1 day
Title
central arterial stiffness
Description
Measurement of central blood pressure and central arterial stiffness simultaneously with the Schiller BR-102 Plus PWA device
Time Frame
1 day
Secondary Outcome Measure Information:
Title
peripheral blood pressure
Description
Measurement peripheral blood pressure with the Schiller BR-102 Plus PWA device
Time Frame
1 day
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Healthy individuals free of clinically relevant cardiovascular diseases or diabetes based on medical history and physical examination.
Heart rhythm: Sinus rhythm
Blood pressure range: 10 to 12 subjects in each of the three systolic blood pressure (SBP) and three diastolic blood pressure (DBP) recruitment ranges (low, medium, high).
Exclusion Criteria:
Cardiac arrhythmia (atrial fibrillation, frequent extrasystoles)
Pacemaker-dependent
Pregnancy after the 6th month of the pregnancy
Body mass index (BMI)>30 kg/m2
Known significant carotid or femoral artery stenosis
Impalpable arterial pulse at site of measurement
Age under 18 years.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Arno Schmidt-Trucksäss, MD, MA
Organizational Affiliation
Department for Sport, Exercise and Health, Sports and Exercise Medicine, University of Basel, Basel, Switzerland, 4052
Official's Role
Principal Investigator
12. IPD Sharing Statement
Learn more about this trial
Validation of the Schiller BR-102 Plus PWA Device to Measure Central and Peripheral Hemodynamics
We'll reach out to this number within 24 hrs